Market Closed -
Other stock markets
|
Pre-market 09:06:11 am | |||
142.6 USD | -5.91% | 141.5 | -0.73% |
02:33pm | COVID shots should target JN.1, KP.2 subvariants in 2024-25 campaign, US FDA staff says | RE |
02:00pm | Moderna-Merck skin cancer vaccine shows survival benefit in long-term follow-up | RE |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+43.36% | 54.63B | |
-5.31% | 39.92B | |
+37.40% | 38.82B | |
+14.75% | 26.86B | |
-12.56% | 26.22B | |
-22.45% | 18.78B | |
+25.12% | 12.21B | |
+0.04% | 12.16B | |
+26.04% | 11.94B | |
-11.83% | 10.74B |
- Stock Market
- Equities
- MRNA Stock
- News Moderna, Inc.
- Sector Update: Health Care